REFERENCES 
1 . Estimates of HIV prevalence and projected AIDS cases: Summary of a workshop, October 3 1 
- November 1,1989. MMWR 39:110-119 (1990). 
2. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic 
retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500 (1984). 
3. Barre-Sinoussi F, Nugeyre M, Dauguet C, et al Isolation of a T-lymphotropic retrovirus from a 
patients at risk for acquired immune deficiency syndrome. Science 220:868 (1983). 
4. Popovic M, Sarngadharon MG, Read E, Gallo RC. Detection, isolation, and continuous 
production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. 
Science 224:497 (1984). 
5. Curran JW, Jaffe HW, Hardy AM. Epidemiology of HIV infection and AIDS in the United 
States. Science 239:610 (1988). 
6. Mann J, Chin J, Piot P, Quinn T. The International Epidemiology of AIDS. Scientific 
American 259:82-89 (1988). 
7. Fauci AS. Combination therapy for HIV infection: getting closer. Ann Intern Med 1 16:85-86 
(1992). 
8. Fisch: MA, Richman DD. Causey DM, et al. Prolonged zidovudine therapy in patients with 
AIDS and advanced AIDS related complex. AZT Collaborative Working Group. JAMA 
262:2405-2410(1989). 
9. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the 
blood of infected persons. NEnglJMed321 :1621 -1625 (1989). 
10. Richman DD. Fischl MA. Grieco MH, et al. The toxicity of azidothymidine (AZT) in the 
treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled 
trial. N Engl J Med 317:192-197 (1987). 
1 1 . Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated 
during prolonged therapy. Science 243:1731 -1734 (1989). 
12. Kenny AB, Hitzig WH. Bone marrow transplantation for severe combined immunodeficiency 
disease. Reported from 1968 to 1977. Eur J Pediatr 131 : 155- 177 (1979). 
13. Vossen JM. Bone marrow transplantation in the treatment of primary immunodeficiencies. 
Ann Clin Res 19:285-292 (1987). 
14. Bortin MM, Rimm AA. Severe combined immunodeficiency disease. Characterization of the 
disease and results of transplantation. JAMA 238:591-600 (1977). 
15. Lane HC, Kovacs JA, Feinberg J. Anti-retroviral effects of interferon-alpha in AIDS- 
associated Kaposi's sarcoma. Lancet 2:1218-1222 (1988). 
16. Rook AH, Masur H, Lane HC, et al. Interleukin-2 enhances the depressed natural killer and 
cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired 
immunodeficiency syndrome. J Clin Invest 72 398-403 (1987). 
17. Lane HC, Masur H Longo D et al. Partial immune reconstitution in a patient with the acquired 
immunodeficiency syndrome. N Engl J Med 311:1 099- 1103 (1 984) 
18. Mitsuyasu R, Volberding,P, Groopman J. et al. Bone marrow transplantation from identical 
twins in the treatment of AIDS and Kaposi's sarcoma [Abstract]. J Cell Biochem 8A:22 
(1987) 
19. Hassett JM, Zaroulis CG, Greenberg ML. et al. Bone marrow transplantation in AIDS [Letter]. 
N Engl J Med 309:665 (1983). 
20. Davis KC, Hayward A, Ozturk G, et al. Lymphocyte transfusion in case of acquired 
immunodeficiency syndrome [Letter]. Lancet 1 :599-600 (1983). 
21. Vilmer E, Rhoces-Feuillette A, Rabian C. et al. Clinical and immunological restoration in 
patients with AIDS after marrow transplantation, using lymphocyte transfusions from the 
marrow donor. Transplantation 44:25-29 (1987). 
Recombinant DNA Research, Volume 19 
[149] 
